None listed
Conditions
Interventions
None listed
Sponsors
Indian Society of Clinical Research
Apollo Research and Innovations
Eligibility
Inclusion criteria
Inclusion criteria: health care workers who have received at least 1 dose of Covishiled or Covaxin between 16 Dec 2020 and 30 Apr 2021
Exclusion criteria
Exclusion criteria: health care workers who did not take any COVID-19 vaccine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Post vaccination infection with COVID-19 (as confirmed by RT PCR and antigen test results) and duration between the last dose and infection and how many doses of vaccines were taken 2) Number and percentage of Adverse events following Immunization (AEFI) will be presented such as: pain at injection site, body ache, fever, hospitalization and reason for hospitalization etcTimepoint: At the time of study data collection | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Association between post vaccination clinical symptoms (as mention in primary end point) and other variables such as a. Age (18-30 years, 31-44 years, 45-59 years and more then 60 years) b. Gender (male, female) c. Name of vaccine (covishield, covaxin) d. Dose of the vaccine (first or second dose) e. Duration between the two doses (how many weeks between the two doses) f. Name of COVID-19 vaccine g. Time from vaccination to symptoms h. Medical and para-medical workers 2) Results of post vaccination antibody Test will be describe if availableTimepoint: At the time of study data collection | — |
Countries
India
Contacts
Public ContactMs Jayanthi Swaminathan
Apollo Research and Innovations
Outcome results
None listed